Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Expanding the targets available to therapeutic antibodies via novel disease-specific markers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Expanding the targets available to therapeutic antibodies via novel disease-specific markers.
Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol. 2011 Oct-Dec; 30(5-6):312-27.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibody Specificity
Antibody Specificity
Cell Line, Tumor
Cell Line, Tumor
Histocompatibility Antigens Class I
Histocompatibility Antigens Class I
Humans
Humans
Immunotherapy
Immunotherapy
Molecular Mimicry
Molecular Mimicry
Neoplasms
Neoplasms
Peptides
Peptides
Receptors, Antigen, T-Cell
Receptors, Antigen, T-Cell
authors with profiles
William H Hildebrand